Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
7501
ProCap Acquisition Corp
PCAP
| $463 | ﹤0.01% |
45
-23
| -34% | -$236 |
2025 Q3
3 quarters
|
|
7502
HCM III Acquisition Corp
HCMA
$348M
| $463 | ﹤0.01% |
45
-23
| -34% | -$234 |
2025 Q4
2 quarters
|
|
7503
PSQ Holdings
PSQH
$14.1M
| $462 | ﹤0.01% |
76
+2
| +3% | +$18 |
2023 Q3
11 quarters
|
|
7504
Oxley Bridge Acquisition Ltd
OBA
$330M
| $460 | ﹤0.01% |
45
-23
| -34% | -$234 |
2025 Q4
2 quarters
|
|
7505
FT Vest Gold Strategy Quarterly Buffer ETF
BGLD
$53.6M
| $457 | ﹤0.01% |
28
-2,425
| -99% | -$41.5K |
2024 Q1
9 quarters
|
|
7506
Medicus Pharma
MDCX
$138K
| $456 | ﹤0.01% |
1,022
-4,446
| -81% | -$1.57K |
2025 Q2
4 quarters
|
|
7507
Kochav Defense Acquisition Corp
KCHV
| $456 | ﹤0.01% |
44
-23
| -34% | -$237 |
2025 Q4
2 quarters
|
|
7508
Leverage Shares 2X Long GLW Daily ETF
GLWG
$88.4M
| $452 | ﹤0.01% |
10
-90
| -90% | -$2.37K |
2026 Q1
1 quarter
|
|
7509
Armada Acquisition Corp III
AACI
$343M
| $450 | ﹤0.01% |
45
+33
| +275% | +$327 |
2026 Q1
1 quarter
|
|
7510
Bold Eagle Acquisition Corp
BEAG
$335M
| $449 | ﹤0.01% |
42
-24
| -36% | -$254 |
2025 Q1
5 quarters
|
|
7511
Art Technology Acquisition Corp
ARTC
$348M
| $447 | ﹤0.01% |
45
+33
| +275% | +$326 |
2026 Q1
1 quarter
|
|
7512
T. Rowe Price Technology ETF
TTEQ
$491M
| $446 | ﹤0.01% |
+10
| New | +$396 |
2026 Q2
0 quarters
|
|
|
IPCX
7513
DELISTED
Inflection Point Acquisition Corp III
IPCX
| $444 | ﹤0.01% |
43
-24
| -36% | -$247 |
2025 Q2
4 quarters
|
|
7514
Daedalus Special Acquisition Corp
DSAC
| $444 | ﹤0.01% |
44
+32
| +267% | +$319 |
2026 Q1
1 quarter
|
|
7515
Blue Water Acquisition Corp III
BLUW
| $443 | ﹤0.01% |
43
-24
| -36% | -$247 |
2025 Q4
2 quarters
|
|
7516
Cohen Circle Acquisition Corp II
CCII
$357M
| $443 | ﹤0.01% |
43
-24
| -36% | -$246 |
2025 Q4
2 quarters
|
|
7517
Oyster Enterprises II Acquisition Corp
OYSE
$353M
| $442 | ﹤0.01% |
43
-24
| -36% | -$246 |
2025 Q3
3 quarters
|
|
7518
Xenetic Biosciences
XBIO
$4.99M
| $437 | ﹤0.01% |
+150
| New | +$463 |
2026 Q2
0 quarters
|
|
7519
GigCapital9 Corp
GIX
$365M
| $437 | ﹤0.01% |
44
+32
| +267% | +$316 |
2026 Q1
1 quarter
|
|
7520
Hennessy Capital Investment Corp
HCIC
| $437 | ﹤0.01% |
44
+33
| +300% | +$326 |
2026 Q1
1 quarter
|
|
7521
First Trust Multi-Strategy Alternative ETF
LALT
$394M
| $433 | ﹤0.01% |
18
-392
| -96% | -$9.63K |
2024 Q4
6 quarters
|
|
7522
BTC Development Corp
BDCI
| $433 | ﹤0.01% |
43
-24
| -36% | -$241 |
2025 Q4
2 quarters
|
|
7523
Dragonfly Energy
DFLI
$884K
| $431 | ﹤0.01% |
220
-11
| -5% | -$22 |
2022 Q4
14 quarters
|
|
|
AEAQ
7524
Activate Energy Acquisition Corp
AEAQ
| $430 | ﹤0.01% |
43
+32
| +291% | +$319 |
2026 Q1
1 quarter
|
|
7525
Soren Acquisition Corp
SORN
$348M
| $427 | ﹤0.01% |
43
+31
| +258% | +$308 |
2026 Q1
1 quarter
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.